查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552662

核酸治療市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034

Nucleic Acid Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 195 Pages | 商品交期: 2-10個工作天內

價格

核酸治療市場 - 報告範圍

TMR 關於全球核酸治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。市場，考慮2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球核酸治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解核酸治療市場。

市場概況
2023年市場價值 60 億美元
2034 年市場價值 221 億美元
複合年成長率 12.8%

該報告深入探討了全球核酸治療市場的競爭格局。全球核酸治療市場的主要參與者已被確定，並且每位參與者的各種屬性都已被描述。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球核酸治療市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 各國監理狀況
  • 技術進步
  • 報銷場景
  • PESTEL分析
  • 波特五力分析
  • 市場影響分析
  • 投資場景
  • 當前治療格局中未滿足的需求

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年各產品市場價值預測
    • 反義寡核苷酸 (ASO)
    • RNA 干擾 (RNAi)
    • RNA適體
  • 按產品分類的市場吸引力

第 7 章：全球市場分析與預測：依指標分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年市場價值預測（依指標）
    • 自體免疫疾病
    • 傳染病
    • 遺傳性疾病
    • 癌症
    • 其他
  • 按指標分類的市場吸引力

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年最終用戶市場價值預測
    • 醫院
    • 醫生辦公室
    • 其他
  • 最終用戶的市場吸引力

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 10 章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 13 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會
  • 南非
  • 中東和非洲其他地區

第15章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2023)
  • 公司簡介
    • Alynylam Pharmaceutials, Inc.
    • BioNTech
    • Ionis Pharmaceuticals, Inc.
    • Moderna
    • Nippon Shinyaku
    • Novartis
    • Pfizer
    • Sarepta Therapeutics
    • Biogen Inc.
    • Genzyme Sanofi
    • Percheron Therapeutics Ltd.
Product Code: TMRGL86333

Nucleic Acid Therapeutics Market - Scope of Report

TMR's report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nucleic acid therapeutics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nucleic acid therapeutics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nucleic acid therapeutics market.

Market Snapshot
Market Value in 2023US$ 6 Bn
Market Value in 2034US$ 22.1 Bn
CAGR12.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nucleic acid therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nucleic acid therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nucleic acid therapeutics market.

The report delves into the competitive landscape of the global nucleic acid therapeutics market. Key players operating in the global nucleic acid therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nucleic acid therapeutics market profiled in this report.

Key Questions Answered in Global nucleic acid therapeutics Market Report:

  • What is the sales/revenue generated by nucleic acid therapeutics across all regions during the forecast period?
  • What are the opportunities in the global nucleic acid therapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nucleic Acid Therapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global nucleic acid therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nucleic acid therapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nucleic acid therapeutics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nucleic Acid Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Regulatory Scenario by Countries
  • 5.3. Technological Advancement
  • 5.4. Reimbursement Scenario
  • 5.5. PESTEL Analysis
  • 5.6. Porter's Five Force Analysis
  • 5.7. Impact Analysis on Market
  • 5.8. Investment Scenario
  • 5.9. Unmet Needs in Current Treatment Landscape

6. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020-2034
    • 6.3.1. Anti-Sense Oligonucleotides (ASO)
    • 6.3.2. RNA Interference (RNAi)
    • 6.3.3. RNA Aptamers
  • 6.4. Market Attractiveness By Product

7. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Indication, 2020-2034
    • 7.3.1. Autoimmune Disorders
    • 7.3.2. Infectious Diseases
    • 7.3.3. Genetic Disorders
    • 7.3.4. Cancer
    • 7.3.5. Others
  • 7.4. Market Attractiveness By Indication

8. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Physicians' Offices
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Nucleic Acid Therapeutics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2020-2034
    • 10.2.1. Anti-Sense Oligonucleotides (ASO)
    • 10.2.2. RNA Interference (RNAi)
    • 10.2.3. RNA Aptamers
  • 10.3. Market Value Forecast By Indication, 2020-2034
    • 10.3.1. Autoimmune Disorders
    • 10.3.2. Infectious Diseases
    • 10.3.3. Genetic Disorders
    • 10.3.4. Cancer
    • 10.3.5. Others
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals
    • 10.4.2. Physicians' Offices
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Nucleic Acid Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2020-2034
    • 11.2.1. Anti-Sense Oligonucleotides (ASO)
    • 11.2.2. RNA Interference (RNAi)
    • 11.2.3. RNA Aptamers
  • 11.3. Market Value Forecast By Indication, 2020-2034
    • 11.3.1. Autoimmune Disorders
    • 11.3.2. Infectious Diseases
    • 11.3.3. Genetic Disorders
    • 11.3.4. Cancer
    • 11.3.5. Others
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals
    • 11.4.2. Physicians' Offices
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Nucleic Acid Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020-2034
    • 12.2.1. Anti-Sense Oligonucleotides (ASO)
    • 12.2.2. RNA Interference (RNAi)
    • 12.2.3. RNA Aptamers
  • 12.3. Market Value Forecast By Indication, 2020-2034
    • 12.3.1. Autoimmune Disorders
    • 12.3.2. Infectious Diseases
    • 12.3.3. Genetic Disorders
    • 12.3.4. Cancer
    • 12.3.5. Others
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals
    • 12.4.2. Physicians' Offices
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Nucleic Acid Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020-2034
    • 13.2.1. Anti-Sense Oligonucleotides (ASO)
    • 13.2.2. RNA Interference (RNAi)
    • 13.2.3. RNA Aptamers
  • 13.3. Market Value Forecast By Indication, 2020-2034
    • 13.3.1. Autoimmune Disorders
    • 13.3.2. Infectious Diseases
    • 13.3.3. Genetic Disorders
    • 13.3.4. Cancer
    • 13.3.5. Others
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals
    • 13.4.2. Physicians' Offices
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Nucleic Acid Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020-2034
    • 14.2.1. Anti-Sense Oligonucleotides (ASO)
    • 14.2.2. RNA Interference (RNAi)
    • 14.2.3. RNA Aptamers
  • 14.3. Market Value Forecast By Indication, 2020-2034
    • 14.3.1. Autoimmune Disorders
    • 14.3.2. Infectious Diseases
    • 14.3.3. Genetic Disorders
    • 14.3.4. Cancer
    • 14.3.5. Others
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals
    • 14.4.2. Physicians' Offices
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Alynylam Pharmaceutials, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. BioNTech
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Ionis Pharmaceuticals, Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Moderna
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Nippon Shinyaku
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Novartis
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Pfizer
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Sarepta Therapeutics
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Biogen Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Genzyme Sanofi
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Percheron Therapeutics Ltd.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 02: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 03: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 4: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 5: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 6: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 7: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 8: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 9: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 11: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 12: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 15: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 16: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 19: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 20: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 23: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 24: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Nucleic Acid Therapeutics Market Size, by Product, 2023
  • Figure 02: Global Nucleic Acid Therapeutics Market share (%), by Product, 2023
  • Figure 03: Global Nucleic Acid Therapeutics Market Size, by Indication, 2023
  • Figure 04: Global Nucleic Acid Therapeutics Market share (%), by Indication, 2023
  • Figure 05: Global Nucleic Acid Therapeutics Market Size, by End-user, 2023
  • Figure 06: Global Nucleic Acid Therapeutics Market share (%), by End-user, 2023
  • Figure 07: Global Nucleic Acid Therapeutics Market, By Region 2023 and 2034
  • Figure 8: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 9: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 10: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023
  • Figure 11: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2034
  • Figure 12: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 13: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Anti-Sense Oligonucleotides (ASO), 2020-2034
  • Figure 14: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Anti-Sense Oligonucleotides (ASO), 2023 and 2034
  • Figure 15: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by RNA Interference (RNAi) , 2020-2034
  • Figure 16: Global Nucleic Acid Therapeutics Market Value Share Analysis, RNA Interference (RNAi) , 2023 and 2034
  • Figure 17: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by RNA Aptamers, 2020-2034
  • Figure 18: Global Nucleic Acid Therapeutics Market Value Share Analysis, by RNA Aptamers, 2023 and 2034
  • Figure 19: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 20: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023
  • Figure 21: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2034
  • Figure 22: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 23: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Autoimmune Disorders (ASO), 2020-2034
  • Figure 24: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Autoimmune Disorders, 2023 and 2034
  • Figure 25: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Infectious Diseases, 2020-2034
  • Figure 26: Global Nucleic Acid Therapeutics Market Value Share Analysis, Infectious Diseases, 2023 and 2034
  • Figure 27: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Genetic Disorders, 2020-2034
  • Figure 28: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Genetic Disorders, 2023 and 2034
  • Figure 29: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Cancer , 2020-2034
  • Figure 30: Global Nucleic Acid Therapeutics Market Value Share Analysis, Cancer , 2023 and 2034
  • Figure 31: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 32: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 33: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 34: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023
  • Figure 35: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2034
  • Figure 36: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 37: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Hospitals, 2020-2034
  • Figure 38: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Hospitals, 2023 and 2034
  • Figure 39: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Physicians' Offices , 2020-2034
  • Figure 40: Global Nucleic Acid Therapeutics Market Value Share Analysis, Physicians' Offices , 2023 and 2034
  • Figure 41: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Others , 2020-2034
  • Figure 42: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Others , 2023 and 2034
  • Figure 43: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 44: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 45: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 46: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 47: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 48: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 49: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 50: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 51: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 52: North America Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 53: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 54: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 55: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 56: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 57: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 58: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 59: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 60: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 61: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 63: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 65: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 66: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 67: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 68: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 69: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 70: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 71: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 72: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 73: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 74: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 75: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 76: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 77: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 78: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 79: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 80: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 81: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 82: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 83: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 84: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 85: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 86: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 87: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 88: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 89: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034